Skip to content
Recall Observatory FDA recall evidence

Drug product

Cephalexin for Oral Suspension, USP 250 mg per 5 mL 200 ml (when mixed) Rx Only, Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-68

D-0264-2021

January 22, 2021

Class II

Product summary

Firm
Ascend Laboratories LLC
Event
Event 87214
Status
Terminated
Classification
Class II
Quantity
23,436 200 mL bottles
Official record key
drug-enforcement:D-0264-2021

Official wording

Reason: CGMP Deviations: Individual Unidentified impurities results of the product was found at higher side of the specification limit.

Code information: Lot #: 19141869, 19141870, EXP 3/2021; 19142762, EXP 5/2021; 19143826, 19143923,19143941, 19143954 EXP 7/2021

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations

Field note

Send feedback

We'll only use this to respond to your feedback.